The USAN program is a collaborative effort between the American Medical Association (AMA), the United States Pharmacopeial Convention (USP), and the American Pharmacists Association (APhA). The process involves extensive review and coordination to ensure that each drug name is clear, distinctive, and free from potential confusion with other drug names.
